Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies

被引:13
作者
Al-Samkari, Hanny [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA
关键词
D O I
10.1177/0194599818813521
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:368 / 368
页数:1
相关论文
共 5 条
[1]   Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia [J].
Al-Samkari, H. ;
Kritharis, A. ;
Rodriguez-Lopez, J. M. ;
Kuter, D. J. .
JOURNAL OF INTERNAL MEDICINE, 2019, 285 (02) :223-231
[2]   Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients [J].
Guilhem, Alexandre ;
Fargeton, Anne-Emmanuelle ;
Simon, Anne-Claire ;
Duffau, Pierre ;
Harle, Jean-Robert ;
Lavigne, Christian ;
Carette, Marie-France ;
Bletry, Olivier ;
Kaminsky, Pierre ;
Leguy, Vanessa ;
Lerolle, Nathalie ;
Roux, Dominique ;
Lambert, Marc ;
Chinet, Thierry ;
Bonnet, Delphine ;
Dupuis-Girod, Sophie ;
Riviere, Sophie .
PLOS ONE, 2017, 12 (11)
[3]   Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis [J].
Hsu, Yuan-Pin ;
Hsu, Chin-Wang ;
Bai, Chyi-Huey ;
Cheng, Sheng-Wei ;
Chen, Chiehfeng .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (01) :22-35
[4]   Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding [J].
Iyer, Vivek N. ;
Apala, Dinesh R. ;
Pannu, Bibek S. ;
Kotecha, Aditya ;
Brinjikji, Waleed ;
Leise, Michael D. ;
Kamath, Patrick S. ;
Misra, Sanjay ;
Begna, Kebede H. ;
Cartin-Ceba, Rodrigo ;
DuBrock, Hilary M. ;
Krowka, Michael J. ;
O'Brien, Erin K. ;
Pruthi, Rajiv K. ;
Schroeder, Darrell R. ;
Swanson, Karen L. .
MAYO CLINIC PROCEEDINGS, 2018, 93 (02) :155-166
[5]   Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective [J].
Kritharis, Athena ;
Al-Samkari, Hanny ;
Kuter, David J. .
HAEMATOLOGICA, 2018, 103 (09) :1433-1443